The AstraZeneca Young Health Programme works to help young people aged 10-24 to take control of their health, especially to combat long-term conditions such as cancers, diabetes, respiratory and heart diseases, and mental ill health. These are often called non-communicable diseases (NCDs).
NCDs are by far the world’s greatest cause of mortality. They kill 41 million people each year, equivalent to 71% of all deaths globally. 15 million of these are ’premature’, occurring between the ages of 30 and 69.1
The Young Health Programme Impact Report shows that a long-term commitment to youth health and addressing NCD risk behaviours can result in positive health outcomes for young people.
Findings from the AstraZeneca Young Health Programme Impact Report, in partnership with Plan International, in Brazil, Indonesia and Kenya illustrate how empowering young people with knowledge can result in them making healthier choices in order to prevent non-communicable diseases. For more results, download the report infographic below.
of girls increased their knowledge about gender equality in Brazil
increase in young people visiting community health clinics in Indonesia
decrease in number of young people who smoke in Kenya
of young people adopted more healthy behaviours, like exercising or quitting smoking, in Indonesia
increase in use of family planning methods in Kenya
increase in boys attending health centres in Brazil
To empower young people and make sustainable change, understanding the impact of our Young Health Programme is crucial. Whilst they may not happen every year, our independent evaluations allow us to take a deep dive into the programme and provide a chance to ensure our interventions are effective. Only by listening to young people’s experiences can we work together to create healthier communities.
1. WHO 2021. Non communicable diseases. [online] Available at: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. [Accessed: June 2021].